| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $-0.1B | $-0.1B | $0.1B | $-0.1B | $0.1B | $0.1B |
| EPS (Basic) | $0.57 | $0.75 | $-1.69 | $-0.95 | $0.92 | $-2.03 | $1.73 | $1.70 |
| EPS (Diluted) | $0.57 | $0.75 | $-1.69 | $-0.95 | $0.87 | $-2.03 | $1.73 | $1.70 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.4B | $3.7B | $4.2B | $5.5B | $5.2B | $4.9B | $5.9B | $4.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.2B | $0.2B | $0.3B | $0.3B | $0.3B | $0.1B | $0.0B |
| Total Liabilities | $3.3B | $2.6B | $3.1B | $4.2B | $3.8B | $3.4B | $4.4B | $3.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.1B | $1.1B | $1.1B | $1.3B | $1.5B | $1.3B | $1.5B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.8B | $0.4B | $1.1B | $-0.5B | $-0.3B | $1.0B | $-1.3B | $-1.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.6B | $-0.6B | $-1.2B | $0.3B | $0.2B | $-0.9B | $1.2B | $1.1B |